Inogen names Andy Reding as CEO, replacing Kevin Smith

Inogen Inc., a medical technology company based in Beverly, Mass., has appointed Andy Reding as its new president and chief executive officer, replacing Kevin Smith. Reding, who has over 30 years of experience in the medical technology industry, joined Inogen as chief operating officer in July. Prior to his current role, Reding held various positions at Viant Medical and Hillrom Respiratory Health, where he led global commercial organizations and oversaw sales, marketing, and research and development.

Elizabeth Mora, chairperson of Inogen’s board of directors, stated that Reding’s leadership transition is timely and that he brings a proven track record in building high-performing teams and scaling complex medtech businesses. Reding expressed his enthusiasm for Inogen's mission and his belief in the company’s potential to sharpen its focus, strengthen execution, and expand access to innovative respiratory solutions. The company will release its financial results for the third quarter ended September 30, 2026.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.